The Headway C13 Breath Test Analyzer (HCBT-01) represents a significant advancement in the diagnosis of Helicobacter pylori infections. This state-of-the-art 13C UBT device is designed to enhance testing efficiency and accuracy, making it an invaluable tool in clinical settings.
Simultaneous Testing Capability
One of the standout features of the Headway HCBT-01 is its ability to automatically test six sets of samples simultaneously. This capability dramatically increases throughput, allowing healthcare professionals to conduct multiple tests in a single session. By accommodating multiple samples, the C13 Breath Test Analyzer not only saves time but also streamlines the diagnostic process, making it an ideal choice for busy medical facilities.
Innovative Detection Method
The HCBT-01 utilizes an innovative approach to detect Helicobacter pylori infections. It measures the slight differences in the absorption peak positions of ¹³CO₂ and ¹²CO₂ in the infrared region. By analyzing the concentrations of these isotopes in breath samples, the analyzer provides precise data crucial for accurate diagnosis.
Isotopic Abundance and Diagnostic Accuracy
To determine if a subject is infected with Helicobacter pylori, the Headway C13 Breath Test Analyzer calculates the change in isotopic abundance of ¹³CO₂ in the breath sample relative to its natural abundance. This change is expressed as DOB (‰), providing a clear indicator of infection. The ability to quantify isotopic variations enhances diagnostic accuracy, ensuring that healthcare providers can make informed decisions based on reliable data.
Conclusion
In summary, the Headway C13 Breath Test Analyzer (HCBT-01) is a cutting-edge diagnostic tool that significantly improves the process of detecting Helicobacter pylori infections. With its simultaneous testing capability, innovative detection method, and focus on isotopic abundance, this 13C Breath Test Analyzer sets a new standard in breath testing.
